RUSCONI, STEFANO

RUSCONI, STEFANO  

Dipartimento di Scienze Biomediche e Cliniche  

Mostra records
Risultati 1 - 20 di 374 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Insidious clinical presentation of uncommon infective endocarditis caused by Cardiobacterium species 2025 Bassani, FrancescoFranzetti, MarcoPavia, ClaudiaRusconi, Stefano + Article (author) -
Use of fexinidazole in gambiense human African trypanosomiasis: a retrospective analysis of cases treated in Lui Hospital, South Sudan (2018-2024) 2025 Basilico, MatteoPettenuzzo, SofiaRusconi, Stefano + Article (author) -
Effectiveness, safety, and patient-reported outcomes of bictegravir/emtricitabine/tenofovir alafenamide in routine clinical care in Italy: 12-Month results from the BICSTaR cohort 2025 Marchetti, GiuliaRusconi, Stefano + Article (author) -
Early Scedosporium apiospermium infection of a soil-contaminated traumatic injury successfully treated with isavuconazole: a case report 2025 Bassani, FrancescoRusconi, Stefano + Article (author) -
Safe Switch to an Oral Two-Drug Regimen Based on Dolutegravir in People With Vertically Acquired HIV-1: An Observational Multicenter Study 2025 Vania GiacometStefano Rusconi + Article (author) -
ORCHESTRA Delphi consensus: clinical management of SARS-CoV-2 infection in people with HIV 2025 Bai, FrancescaGatti, MiloMonforte, Antonella d'ArminioBonora, StefanoGiacomelli, AndreaLapadula, GiuseppeMarchetti, GiuliaPerno, Carlo FedericoRusconi, StefanoPiconi, StefaniaAugello, MatteoSavoldi, AlessiaPezzani, Maria Diletta + Article (author) -
Question and answers on long-acting therapy with cabotegravir and rilpivirine in people with HIV 2025 Taramasso, LuciaBonora, StefanoMarchetti, GiuliaNozza, SilviaRusconi, Stefano + Article (author) -
Genomic Epidemiology of the Main SARS‐CoV‐2 Variants Circulating in Italy During the Omicron Era 2025 Bergna, AnnalisaLai, AlessiaSagradi, FabioRusconi, StefanoMbissam, Harcel Djayadella Ventura, CarlaGabrieli, AriannaCanavesi, GiadaRiva, AgostinoAntinori, SpinelloZehender, Gianguglielmo + Article (author) -
Unconventional use of injectable long-acting cabotegravir and rilpivirine against HIV-1 in PWH in clinical need: 52 weeks real-world data 2025 Rossotti, RobertoD'Amico, FedericoRusconi, Stefano + Article (author) -
Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced dimalsease: a trial emulation 2025 Giacomelli, AndreaRaimondi, AlessandroAntinori, SpinelloMarchetti, Giulia CarlaMonforte, Antonella d'ArminioMarchetti, GPerno, CFBandera, ABonora, SGiacomelli, ALapadula, GPiconi, SRusconi, SSantoro, MMTaramasso, LCernuschi, MFarinella, MAugello, MRovito, RSuardi, CMenzaghi, BPan, ASegala, DCanavesi, GCossu, MVMoioli, MCPezzati, LTincati, CBonfanti, PDi Filippo, GMastroianni, C + Article (author) -
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort 2025 Stefano RusconiGiulia MarchettiAntonella d'Arminio MonforteS AntinoriA BanderaA GiacomelliM AugelloA PanC Tincati + Article (author) -
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort 2025 Antinori, SMarchetti, G CPerno, C FBandera, ABonora, SCalcagno, Ad'Arminio Monforte, AGiacomelli, ALapadula, GPiconi, SRossotti, RRusconi, SSantoro, M MTaramasso, LPastorino, RCernuschi, MFarinella, MAugello, MRovito, RSuardi, CMenzaghi, BPan, ASegala, DCanavesi, GAntinori, SBono, VCossu, M VMoioli, M CPezzati, LTincati, CBonfanti, PDi Filippo, GMastroianni, C + Article (author) -
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 2025 Giacomelli, Andread'Arminio Monforte, AntonellaAntinori, SpinelloAugello, MatteoBandera, AlessandraBonfanti, PaoloBono, ValeriaBonora, StefanoCanavesi, GiadaCossu, Maria VittoriaGori, AndreaLai, AlessiaLazzarin, AdrianoMarchetti, GiuliaMenzaghi, BarbaraMoioli, Maria CristinaPerno, Carlo FedericoPezzati, LauraPiconi, StefaniaRossotti, RobertoRovito, RobertaRusconi, StefanoSantoro, CarmenSuardi, ClaudiaTaramasso, LuciaTincati, Camilla + Article (author) -
Switching to dolutegravir plus rilpivirine versus maintaining current antiretroviral therapy regimen in virologically suppressed people with HIV-1 and the Lys103Asn (K103N) mutation: 48-week results from a randomised, open-label pilot clinical trial 2024 Rusconi, Stefano + Article (author) -
Use of ICD-9-CM coding for identifying antibiotic prescriptions during hospitalization: a Delphi consensus model 2024 Genovese, CamillaBozzi, GiorgioMarchetti, Giulia CarlaRusconi, StefanoGori, AndreaBandera, Alessandra + Article (author) -
A cautionary note on entry and exit strategies with long-acting cabotegravir and rilpivirine 2024 Rusconi, Stefano + Article (author) -
Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry 2024 Rusconi, Stefano + Article (author) -
Assessing ChatGPT's Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity 2024 Marchetti, GiuliaRusconi, Stefano + Article (author) -
Plasma, Intracellular and Lymph Node Antiretroviral Concentrations and HIV DNA Change During Primary HIV Infection: Results from the INACTION P25 Study 2024 Marchetti, GiuliaGori, AndreaRusconi, StefanoGabrieli, AriannaBandera, Alessandra + Article (author) -
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors 2024 Marchetti, GiuliaRusconi, Stefano + Article (author) -